Bank of America Boosts AbbVie (NYSE:ABBV) Price Target to $204.00
AbbVie (NYSE:ABBV – Get Free Report) had its target price upped by investment analysts at Bank of America to $204.00 in a research note issued to investors on Monday, Stock Target Advisor reports. The brokerage presently has a “hold” rating on the stock. Bank of America‘s target price indicates a potential upside of 7.76% from […]
